1. Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy
   Seyed Mohammadmahdi Meybodi et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
2. Harnessing Pyroptosis for Lung Cancer Therapy: The Impact of NLRP3 Inflammasome Activation
   Rajiv Dahiya et al, 2024, Pathology - Research and Practice CrossRef
3. Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
   Miguel A. Ortega et al, 2023, Frontiers in Immunology CrossRef
4. Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia
   Xing Ye et al, 2024, Experimental Cell Research CrossRef
5. Mitochondrial DNA and Inflammation in Alzheimer’s Disease
   Giacoma Galizzi et al, 2023, Current Issues in Molecular Biology CrossRef
6. Translational Relevance of Advanced Age and Atherosclerosis in Preclinical Trials of Biotherapies for Peripheral Artery Disease
   Keith A. Webster, 2024, Genes CrossRef
7. Exploring Inflammasome Complex as a Therapeutic Approach in Inflammatory Diseases
   Sharmim Sultana et al, 2023, Future Pharmacology CrossRef
8. The Potential of NOD-like Receptor Protein 3 Inflammasome Inhibitors in the Treatments of Diseases
   Ahmed F. Abdel-Magid, 2023, ACS Medicinal Chemistry Letters CrossRef
9. Impact of inflammasomes on the ocular surface
   Gwen S. Stinnett et al, 2024, Current Opinion in Allergy & Clinical Immunology CrossRef
10. Discovery of NLRP3 inhibitors using machine learning: Identification of a hit compound to treat NLRP3 activation-driven diseases
    Cheng Shi et al, 2023, European Journal of Medicinal Chemistry CrossRef
11. Pyroptosis and inflammation‑mediated endothelial dysfunction may act as key factors in the development of erectile dysfunction (Review)
    Bingbing Zhu et al, 2023, Molecular Medicine Reports CrossRef
12. Inhibition of Immunoproteasome Attenuates NLRP3 Inflammasome Response by Regulating E3 Ubiquitin Ligase TRIM31
    Yubin Lee et al, 2024, Cells CrossRef
13. Crosstalk of NLRP3 inflammasome and noncoding RNAs in cardiomyopathies
    Negar Jafari et al, 2023, Cell Biochemistry and Function CrossRef
14. Personalized Nutritional Strategies to Reduce Knee Osteoarthritis Severity and Ameliorate Sarcopenic Obesity Indices: A Practical Guide in an Orthopedic Setting
    Hassan Zmerly et al, 2023, Nutrients CrossRef
15. Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
    Sara Bindoli et al, 2024, Drugs CrossRef
16. Stroke Related Brain–Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms
    Xuehui Fan et al, 2024, Advanced Science CrossRef
17. Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023
    Meibo Duan et al, 2023, European Journal of Medicinal Chemistry CrossRef
18. Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer
    Shaimaa Hamza et al, 2024, Pharmaceuticals CrossRef
19. Remote-controlled dexamethasone-duration on eye-surface with a micelle-magnetic nanoparticulate co-delivery system for dry eye disease
    Qinxiang Zheng et al, 2024, Acta Pharmaceutica Sinica B CrossRef
20. The Past and Future of Inflammation as a Target to Cancer Prevention
    Laura Antonucci et al, 2024, Cancer Prevention Research CrossRef
21. Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
    Tao Ye et al, 2023, Cytokine & Growth Factor Reviews CrossRef
22. From Innate Immunity to Metabolic Disorder: A Review of the NLRP3 Inflammasome in Diabetes Mellitus
    Iris Maria Nițulescu et al, 2023, Journal of Clinical Medicine CrossRef
23. Neuroinflammation in Alzheimer’s Disease: A Potential Role of Nose-Picking in Pathogen Entry via the Olfactory System?
    Xian Zhou et al, 2023, Biomolecules CrossRef
24. NLRP inflammasomes in health and disease
    Zhihao Xu et al, 2024, Molecular Biomedicine CrossRef